Allianz Asset Management GmbH Has $15.69 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Key Points

• Allianz Asset Management GmbH reduced its stake in The Cooper Companies by 4.8%, owning a total of 185,981 shares valued at approximately $15.7 million as of its latest SEC filing.
• Several large investors, including T. Rowe Price and JPMorgan Chase, have increased their holdings in The Cooper Companies, indicating ongoing institutional interest in the company.
• The Cooper Companies reported Q2 earnings of $0.96 per share, beating analysts' expectations, with revenue of $1 billion for the quarter, a growth of 6.3% year-over-year.

Allianz Asset Management GmbH cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 185,981 shares of the medical device company's stock after selling 9,384 shares during the period. Allianz Asset Management GmbH owned 0.09% of Cooper Companies worth $15,687,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of COO. Covestor Ltd boosted its holdings in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after buying an additional 120 shares during the period. Shell Asset Management Co. boosted its holdings in Cooper Companies by 15.5% in the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock valued at $87,000 after purchasing an additional 127 shares during the period. UMB Bank n.a. boosted its holdings in Cooper Companies by 16.7% in the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after purchasing an additional 129 shares during the period. Axxcess Wealth Management LLC boosted its holdings in Cooper Companies by 1.9% in the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock valued at $623,000 after purchasing an additional 140 shares during the period. Finally, Mitchell & Pahl Private Wealth LLC boosted its holdings in Cooper Companies by 1.8% in the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock valued at $732,000 after purchasing an additional 157 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. UBS Group raised shares of Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Wells Fargo & Company dropped their target price on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research report on Friday, May 30th. Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Robert W. Baird lowered their price objective on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research report on Friday, May 30th. Finally, JPMorgan Chase & Co. reiterated a "neutral" rating and set a $76.00 price objective (down from $110.00) on shares of Cooper Companies in a research report on Friday, May 30th. Three analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $96.73.

Cooper Companies Trading Up 1.1%

NASDAQ:COO traded up $0.79 during trading hours on Friday, hitting $74.59. 1,284,877 shares of the company were exchanged, compared to its average volume of 2,716,910. The stock has a market capitalization of $14.92 billion, a price-to-earnings ratio of 36.21, a price-to-earnings-growth ratio of 1.82 and a beta of 0.99. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a one year low of $65.00 and a one year high of $112.38. The company has a fifty day simple moving average of $73.14 and a 200 day simple moving average of $81.33.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same period in the prior year, the firm posted $0.85 EPS. The company's quarterly revenue was up 6.3% on a year-over-year basis. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.